Crystalline forms of gemcitabine amide prodrug, compositions and use thereof

Details for Australian Patent Application No. 2007261002 (hide)

Owner Eli Lilly and Company

Inventors Oblezov, Alexandr Yevgenyevich

Agent Spruson & Ferguson

Pub. Number AU-B-2007261002

PCT Pub. Number WO2007/149891

Priority 60/815,508 21.06.06 US; 60/815,407 21.06.06 US

Filing date 20 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 8 March 2012

International Classifications

C07H 19/073 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/149891 Priority application(s): WO2007/149891

8 March 2012 Application Accepted

  Published as AU-B-2007261002

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007261003-Method and apparatus for encrypted communications using IPsec keys

2007260991-Crystal structure of OX40L and OX40L complexed with OX40 receptor